| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/30/2004 | CA2519125A1 Dispersible formulation of an anti-inflammatory agent |
| 09/30/2004 | CA2519092A1 Branched water-soluble polymers and their conjugates |
| 09/30/2004 | CA2518836A1 Drug formulations having long and medium chain triglycerides |
| 09/30/2004 | CA2518834A1 Oxycodone conjugates with lower the abuse potential and extended duration of action |
| 09/30/2004 | CA2518327A1 Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides |
| 09/29/2004 | EP1462125A2 Adhesive antineoplastic compositions |
| 09/29/2004 | EP1462116A1 Composition for treating the gastrointestinal tract |
| 09/29/2004 | EP1462112A1 Remedies for dry eye and diseases associated with dry eye |
| 09/29/2004 | EP1462109A1 Hemostatic, emollient and lubricating preparations containing pork fat extract (lard) |
| 09/29/2004 | EP1462101A1 Drinkable preparation comprising ketoprofen and the use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 09/29/2004 | EP1462100A1 Composition comprising formoterol and a glucosorticosteroid |
| 09/29/2004 | EP1462096A1 Methods and compositions for pulmonary delivery of insulin |
| 09/29/2004 | EP1461436A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 09/29/2004 | EP1461369A2 Block copolymers |
| 09/29/2004 | EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 09/29/2004 | EP1461122A2 Treatment of genitourinary tract disorders |
| 09/29/2004 | EP1461090A2 Composition and method for treatment of otitis media |
| 09/29/2004 | EP1461085A2 Immunoconjugates useful for treatment of tumours |
| 09/29/2004 | EP1461084A2 Guanidinium transport reagents and conjugates |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1461074A2 Agents for enhancing the immune response |
| 09/29/2004 | EP1461067A1 Compositions and method for treating hepatitis virus infection |
| 09/29/2004 | EP1461057A1 A topical anti-itch formulation and a process for the preparation thereof |
| 09/29/2004 | EP1461056A2 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 09/29/2004 | EP1461044A1 Pharmaceutical compositions comprising active vitamin d compounds |
| 09/29/2004 | EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation |
| 09/29/2004 | EP1461031A2 Formulations for oral administration of cromolyn sodium |
| 09/29/2004 | EP1461030A1 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 09/29/2004 | EP1461029A1 Taxane based compositions and methods of use |
| 09/29/2004 | EP1461024A1 Treatment of wounds and compositions employed |
| 09/29/2004 | EP1461023A2 Prospective identification and characterization of breast cancer stem cells |
| 09/29/2004 | EP1461021A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 09/29/2004 | EP1461019A2 Bioadhesive drug delivery system with enhanced gastric retention |
| 09/29/2004 | EP1461015A2 Compositions containing both sedative and non-sedative antihistamines |
| 09/29/2004 | EP1461014A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/29/2004 | EP1460995A1 Transdermal transport of compounds |
| 09/29/2004 | EP1460992A2 Stabilized reverse micelle compositions and uses thereof |
| 09/29/2004 | EP1425077A4 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water |
| 09/29/2004 | EP1289495B1 Process for the preparation of a sterile ointment containing acyclovir |
| 09/29/2004 | EP1276510B1 Coloured ophthalmic product |
| 09/29/2004 | EP1272180B1 Concentrated solutions of carvedilol |
| 09/29/2004 | EP1254143B1 Lipid-based drug delivery systems |
| 09/29/2004 | EP1178838B1 Macromolecular carrier based on dextran for drug and diagnostic agent delivery |
| 09/29/2004 | EP1156812A4 Multiparticulate formulation |
| 09/29/2004 | EP1124563B1 Methods and compositions for the prevention of tolerance to bronchodilators |
| 09/29/2004 | EP1083879B1 Devices for providing prolonged drug therapy |
| 09/29/2004 | EP1059915B1 Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 09/29/2004 | EP1059913B1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/29/2004 | EP1030688B1 Method for dermally administering polypeptides |
| 09/29/2004 | EP1003503B1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 09/29/2004 | EP0989848B1 Film-coated tablet for improved upper gastrointestinal tract safety |
| 09/29/2004 | EP0975790B1 New method for isolating polysaccharides |
| 09/29/2004 | EP0969813B1 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 09/29/2004 | EP0952824B1 Enteric coating, comprising alginic acid, for an oral preparation |
| 09/29/2004 | EP0938295B1 A non-aqueous orally administrable, paste-like composition for veterinary use, a method for the preparation thereof, and the use of an oily vehicle for the manufacture of such composition |
| 09/29/2004 | EP0781134B9 Scopolamine plaster |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/29/2004 | EP0616508B2 Gas filled liposomes and their use as ultrasonic contrast agents |
| 09/29/2004 | CN1533442A Cimeric immunomodulatory compounds and methods of using the same |
| 09/29/2004 | CN1533434A Inflenza vaccine composition |
| 09/29/2004 | CN1533286A Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 09/29/2004 | CN1533280A Carbohydrate modifying agent and drinks containing the same |
| 09/29/2004 | CN1533272A Zinc containing compositions for anti-viral use |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/29/2004 | CN1533268A Pharmaceutical composition which comprise solid dispersion of hydroxypropylethyl cellulose phthalate polymer |
| 09/29/2004 | CN1531967A Use of mometasone furoate for treating airway nassage and lung diseases |
| 09/29/2004 | CN1531931A Method for improving solubility of clarithromycin |
| 09/29/2004 | CN1168733C Novel prodrugs for therapy of tumors and inflammatory disorders |
| 09/29/2004 | CN1168503C Veterinarian virus kind biological product heat resistig freeze drying protective agent and its preparation technique |
| 09/29/2004 | CN1168494C Injection-type compound bone repairing material containing more biological factors and using animal fibrin as carrier |
| 09/29/2004 | CN1168454C Jusheng oil and preparation process |
| 09/29/2004 | CN1168452C Use of methoxymorpholino dexorubicin for treatment of liver tumor |
| 09/29/2004 | CN1168448C Medicament for preventing and/or treating a memmary carcinoma, containing a steroidal aromatase inhibitor |
| 09/29/2004 | CN1168440C Levodopa/carbidopa/entacapone pharmaceutical preparation |
| 09/29/2004 | CN1168438C Shellac-containing cosmetic product |
| 09/28/2004 | US6797835 Phospholipid composition and use of same |
| 09/28/2004 | US6797732 Oral solid for treating parkinson's disease where a subtantial portion of carbidopa is separate from entacapone and levodopa |
| 09/28/2004 | US6797701 Topical mixture; containing avermectin, milbemycin |
| 09/28/2004 | US6797521 Fluorescent cobalamin for use in the diagnosis and imaging of cancer |
| 09/28/2004 | US6797291 Comprises protective lipid coating (hydrogenated oils) for choline chloride or lysine hydrochloride; ruminant feeds |
| 09/28/2004 | US6797283 Gastric retention dosage form having multiple layers |
| 09/28/2004 | US6797281 Esters of I-carnitine or alkanoyl I-carnitines |
| 09/28/2004 | US6797280 Pressure-sensitive adhesive composition and moisture-permeable pressure-sensitive adhesive tape, pressure-sensitive adhesive drug composition, and pressure-sensitive adhesive tape preparation each containing the composition |
| 09/28/2004 | US6797276 Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
| 09/28/2004 | US6797272 Enhanced immunogenicity using leukotoxin chimeras |
| 09/28/2004 | US6797270 Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
| 09/28/2004 | US6797262 Film forming compositions for topical use and delivery of active ingredients |
| 09/28/2004 | US6797259 Delivery of muscle relaxants through an inhalation route |
| 09/28/2004 | CA2424003A1 Anti-microbial topical composition comprising alcohol and chlorhexidine salt |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/28/2004 | CA2109028C Stabilized sorbic acid or salt thereof |
| 09/23/2004 | WO2004081533A2 Vault and vault-like carrier molecules |
| 09/23/2004 | WO2004081188A2 Non-toxic membrane-translocating peptides |
| 09/23/2004 | WO2004081056A2 Controlled release polymeric gels |
| 09/23/2004 | WO2004081053A1 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 09/23/2004 | WO2004081051A1 Bispecific antibodies |
| 09/23/2004 | WO2004081031A2 Thiol-mediated drug attachment to targeting peptides |
| 09/23/2004 | WO2004080490A2 Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 09/23/2004 | WO2004080481A1 Novel nph insulin preparations |